Research ArticleOriginal Article
Open Access

Glycemic control, complications, and associated autoimmune diseases in children and adolescents with type 1 diabetes in Jeddah, Saudi Arabia

Abdulmoein E. Al-Agha, Maram Alafif and Ihab A. Abd-Elhameed
Saudi Medical Journal January 2015, 36 (1) 26-31; DOI: https://doi.org/10.15537/smj.2015.1.9829

References

  1. ↵
    (2013) International Diabetes Federation. IDF Diabetes Atlas (International Diabetes Federation, Brussels (Belgium)) Available from: http://www.idf.org/diabetesatlas. 6th ed.
  2. ↵
    1. Al-Herbish AS,
    2. El-Mouzan MI,
    3. Al-Salloum AA,
    4. Al-Qurachi MM,
    5. Al-Omar AA
    (2008) Prevalence of type 1 diabetes mellitus in Saudi Arabian children and adolescents. Saudi Med J 29:1285–1288.
    OpenUrlPubMedWeb of Science
  3. ↵
    1. Barker JM,
    2. Yu J,
    3. Yu L,
    4. Wang J,
    5. Miao D,
    6. Bao F,
    7. et al.
    (2005) Autoantibody “subspecificity” in type 1 diabetes. Diabetes Care 28:850–855.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Hummel S,
    2. Hummel M,
    3. Banholzer J,
    4. Hanak D,
    5. Mollenhauer U,
    6. Bonifacio E,
    7. et al.
    (2007) Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia 50:390–394.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    (2011) International Society for Pediatric and Adolescent Diabetes. ISPAD. Available from: http://www.idf.org/sites/default/files/Diabetes-in-Childhood-and-Adolescence-Guidelines.pdf.
  6. ↵
    1. Al-Agha A,
    2. Ocheltree A,
    3. Hakeem A
    (2011) Thyroid dysfunction in children and adolescents with type 1 diabetes mellitus. J Pediatr Sci 3:93.
    OpenUrl
  7. ↵
    1. Donaghue KC,
    2. Chiarelli F,
    3. Trotta D,
    4. Allgrove J,
    5. Dahl-Jorgensen K
    (2009) Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes 10(Suppl 12):195–203.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    (2003) American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 26:2194.
    OpenUrlFREE Full Text
  9. ↵
    1. Holick MF
    (2008) Diabetes and the vitamin D connection. Curr Diab Rep 8:393–398.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Simsek DG,
    2. Aycan Z,
    3. Özen S,
    4. Cetinkaya S,
    5. Kara C,
    6. Abali S,
    7. et al.
    (2013) Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. J Clin Res Pediatr Endocrinol 5:20–26.
    OpenUrl
  11. ↵
    1. Alvi NS,
    2. Davies P,
    3. Kirk JM,
    4. Shaw NJ
    (2001) Diabetic ketoacidosis in Asian children. Arch Dis Child 85:60–61.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    (1991) Diabetes Control and Complications Trial Research Group. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med 90:450–459.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Fritsch M,
    2. Rosenbauer J,
    3. Schober E,
    4. Neu A,
    5. Placzek K,
    6. Holl RW,
    7. et al.
    (2011) German competence network diabetes mellitus and the DPV initiative. Predictors in diabetic ketoacidosis in children and adolescents with type 1 diabetes. Experience from a large multicenter database. Pediatr Diabetes 12:307–312.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Sasongko MB,
    2. Wang JJ,
    3. Donaghue KC,
    4. Cheung N,
    5. Benitez-Aguirre P,
    6. Jenkins A,
    7. et al.
    (2010) Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care 33:1331–1336.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Donaghue KC,
    2. Craig ME,
    3. Chan AK,
    4. Fairchild JM,
    5. Cusumano JM,
    6. Verge CF,
    7. et al.
    (2005) Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes. Diabet Med 22:711–718.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Gallego PH,
    2. Bulsara MK,
    3. Frazer F,
    4. Lafferty AR,
    5. Davis EA,
    6. Jones TW
    (2006) Prevalence and risk factors for microalbuminuria in a population-based sample of children and adolescents with T1DM in Western Australia. Pediatr Diabetes 7:165–172.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Holl RW,
    2. Grabert M,
    3. Thon A,
    4. Heinze E
    (1999) Urinary excretion of albumin in adolescents with type 1 diabetes. Diabetes Care 22:1555–1560.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Maahs DM,
    2. Dabelea D,
    3. D’Agostino RB Jr.,
    4. Andrews JS,
    5. Shah AS,
    6. Crimmins N,
    7. et al.
    (2013) Glucose control predict 2-year change in lipid profile in youth with type 1 diabetes. J Pediatr 162:101–107.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Pozzilli P,
    2. Manfrini S,
    3. Crinò A,
    4. Picardi A,
    5. Leomanni C,
    6. Cherubini V,
    7. et al.
    (2005) Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res 37:680–683.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Borkar VV,
    2. Verma S,
    3. Bhalla AK
    (2010) Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes 11:345–350.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Bonifacio E,
    2. Mayr A,
    3. Knopff A,
    4. Ziegler AG
    (2009) Endocrine autoimmunity in families with type 1 diabetes: frequent appearance of thyroid autoimmunity during late childhood and adolescence. Diabetologia 52:185–192.
    OpenUrl
  22. ↵
    1. Karavanaki K,
    2. Kakleas K,
    3. Paschali E,
    4. Kefalas N,
    5. Konstantopoulos I,
    6. Petrou V,
    7. et al.
    (2009) Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus (T1DM). Horm Res 71:201–206.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Saadah OI,
    2. Al-Agha AE,
    3. Al Nahdi HM,
    4. Bokhary RY,
    5. Bin Talib YY,
    6. Al-Mughales JA,
    7. et al.
    (2012) Prevalence of celiac disease in children with type 1 diabetes mellitus screened by anti-tissue transglutaminase antibody from Western Saudi Arabia. Saudi Med J 33:541–546.
    OpenUrlPubMed
  24. ↵
    1. Sakly W,
    2. Bienvenu F,
    3. Peretti N,
    4. Lachaux A,
    5. Morel S,
    6. Bouvier R,
    7. et al.
    (2005) IgA anti transglutaminase antibodies as a tool for screening atypical forms of coeliac disease in a French at-risk paediatric population. Eur J Gastroenterol Hepatol 17:235–239.
    OpenUrlPubMed
  25. ↵
    1. Al-Hussaini A,
    2. Sulaiman N,
    3. Alzahrani M,
    4. Alenizi A,
    5. El-Haj I
    (2012) High prevalence of celiac disease among Saudi children with type 1 diabetes: a prospective cross sectional study. BMC Gastroenterol 12:180.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Crone J,
    2. Rami B,
    3. Huber WD,
    4. Granditsch G,
    5. Schober E
    (2003) Prevalence of celiac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 37:67–71.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section